Brickell Biotech
Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD55—82m (Dealroom.co estimates Feb 2015.)
Boulder Colorado (HQ)
Authorizing premium user...